Basics |
Company: |
ABBVIE INC. |
IPO Date: |
December 14, 2012 |
Sector: |
Healthcare |
Industry: |
Drug Manufacturers |
Market Cap: |
$335.67B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.93 | 1.01%
|
Avg Daily Range (30 D): |
$1.69 | 0.96%
|
Avg Daily Range (90 D): |
$1.75 | 0.96%
|
Institutional Daily Volume |
Avg Daily Volume: |
6.35M |
Avg Daily Volume (30 D): |
4.22M |
Avg Daily Volume (90 D): |
4.27M |
Trade Size |
Avg Trade Size (Sh.): |
110 |
Avg Trade Size (Sh.) (30 D): |
59 |
Avg Trade Size (Sh.) (90 D): |
57 |
Institutional Trades |
Total Inst.Trades: |
59,083 |
Avg Inst. Trade: |
$9.11M |
Avg Inst. Trade (30 D): |
$21.79M |
Avg Inst. Trade (90 D): |
$22.98M |
Avg Inst. Trade Volume: |
.09M |
Avg Inst. Trades (Per Day): |
19 |
Market Closing Trades |
Avg Closing Trade: |
$83.25M |
Avg Closing Trade (30 D): |
$202.48M |
Avg Closing Trade (90 D): |
$203.78M |
Avg Closing Volume: |
783.55K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$2.87
|
$.88
|
$.77
|
Diluted EPS
|
$2.87
|
$.88
|
$.77
|
Revenue
|
$ 55.53B
|
$ 14.46B
|
$ 14.46B
|
Gross Profit
|
$ 37.32B
|
$ 10.25B
|
$ 10.26B
|
Net Income / Loss
|
$ 5.13B
|
$ 1.56B
|
$ 1.37B
|
Operating Income / Loss
|
$ 13.82B
|
$ 3.83B
|
$ 4B
|
Cost of Revenue
|
$ 18.21B
|
$ 4.21B
|
$ 4.2B
|
Net Cash Flow
|
$ -6030M
|
$ -5873M
|
$ -4937M
|
PE Ratio
|
66.29
|
|
|
|